CEACAM5 and colorectal carcinoma: An alphavirus SAM-RNA vaccine, known as virus-like replicon particle (VRP)-CEA (6D) vaccine or AVX701, has been investigated in two clinical trials for the treatment of stage III CRC and advanced or metastatic CEA-expressing tumors (NCT00529984, NCT01890213) (126, 140).